R S Misra Selected Research

Lepromin

6/2000	Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment.
6/2000	Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine.
6/2000	Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R S Misra Research Topics

Disease

4	Leprosy (Hansen's Disease) 12/2000 - 06/2000
3	Multibacillary Leprosy 06/2000 - 06/2000
2	Erythema Nodosum 12/2000 - 12/2000
2	Lepromatous Leprosy 12/2000 - 12/2000
2	Neuritis (Polyneuritis) 06/2000 - 06/2000
1	Chronic Disease (Chronic Diseases) 12/2000
1	Tuberculoid Leprosy 12/2000

Drug/Important Bio-Agent (IBA)

3	LeprominIBA 06/2000 - 06/2000
3	VaccinesIBA 06/2000 - 06/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2000 - 12/2000
2	CytokinesIBA 12/2000 - 12/2000
2	Mycobacterium w vaccineIBA 06/2000 - 06/2000
1	Interleukin-4 (Interleukin 4)IBA 12/2000
1	Interleukin-10 (Interleukin 10)IBA 12/2000
1	Interferon-gamma (Interferon, gamma)IBA 12/2000
1	Interleukin-12 (IL 12)IBA 12/2000
1	anti-leprosy vaccineIBA 06/2000

Therapy/Procedure

2	Therapeutics 06/2000 - 06/2000
1	Aftercare (After-Treatment) 06/2000
1	Immunotherapy 06/2000